Rubio-Cabezas, O.

patient discoloration glibenclamide diabetes tooth discoloration tooth kcnj 11 mutation mutation teeth transfer effect sulfonylurea glibenclamide dose month blood fl ow fi ve patients novel side effect enamel insulin patient 2 therapy deciduous teeth tablet control research chicago association treatment deciduou conclusions — ashcroft fm identi fied channel methods — hattersley sulfonylurea therapy novel 67 patients high-dose glibenclamide exeter association warrants article caucasian sulfonylurea treatment 6.2 tooth staining fructosamine flanagan kir 6.2 subunit peninsula nj ølstad pr 2009 lar doses blood kcnj 11 diabetes high-dose development department delay “ advertisement ” ellard 0.6 surface 0.8 school research fellow k ϩatp channels 0.7 volume associates table 1— features glycemic control hospital number glibenclamide therapy hattersley monitoring glycemic control 3– 4 months type 2 diabetes 0.9 kir 6.2 mutations 1430 lecki mt kovler family foundation cause